Laekna, Inc.
Status: Publicly traded
Direct answer
Laekna, Inc. is publicly traded on HKSE under the ticker 2105.HK.
Laekna, Inc., an investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis worldwide. The company offers LAE002, an adenosine triphosphate competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, and breast cancer; LAE001, an androgen synthesis inhibitor that inhibits CYP17A1 and...
Can you invest in Laekna, Inc.?
Yes. Laekna, Inc. is publicly traded on HKSE under the ticker 2105.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Laekna, Inc.
Detailed equity research is provided by MarketSnap.